JPH0769864A - Effervescent tablet type bath agent containing capsules - Google Patents

Effervescent tablet type bath agent containing capsules

Info

Publication number
JPH0769864A
JPH0769864A JP21296893A JP21296893A JPH0769864A JP H0769864 A JPH0769864 A JP H0769864A JP 21296893 A JP21296893 A JP 21296893A JP 21296893 A JP21296893 A JP 21296893A JP H0769864 A JPH0769864 A JP H0769864A
Authority
JP
Japan
Prior art keywords
active ingredient
liquid
oil
bath agent
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP21296893A
Other languages
Japanese (ja)
Other versions
JP2544297B2 (en
Inventor
Hidenori Yorozu
秀憲 萬
Norikazu Iwase
範和 岩瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP5212968A priority Critical patent/JP2544297B2/en
Publication of JPH0769864A publication Critical patent/JPH0769864A/en
Application granted granted Critical
Publication of JP2544297B2 publication Critical patent/JP2544297B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

(57)【要約】 【構成】 核含有錠剤型浴用剤において、核部分に液状
成分を封入してなるカプセル化物を含有し、その核外部
分に発泡性浴用成分を含有することを特徴とする発泡性
錠剤型浴用剤。 【効果】 液状の有効成分のしみ出しや、分解、変質が
なく経時的に安定である。
(57) [Summary] [Structure] A core-containing tablet type bath agent is characterized in that it contains an encapsulated product in which a liquid component is encapsulated in the core part, and contains an effervescent bath component in the extra-core part. Effervescent tablet type bath agent. [Effect] It is stable over time without exudation, decomposition or alteration of the liquid active ingredient.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、打錠時の圧力による有
効成分のしみ出しがなく、有効成分の分解が少ないカプ
セル含有発泡性錠剤型浴用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a capsule-containing effervescent tablet-type bath preparation which does not exude the active ingredient due to the pressure during tableting and has less decomposition of the active ingredient.

【0002】[0002]

【従来の技術】生薬抽出物等の液状有効成分を発泡性錠
剤型浴用剤に配合する方法としては、液状有効成分をデ
キストリン等の吸油剤に吸着させ錠剤中に均一に分散さ
せる方法、又は吸油剤に有効成分を吸収させ顆粒又は錠
剤とし、これを核として炭酸塩及び酸を含有する発泡成
分中に混入して打錠する方法があった(特開昭61−2
77611号公報)。
2. Description of the Related Art As a method for compounding a liquid active ingredient such as a crude drug extract into an effervescent tablet type bath agent, a method in which the liquid active ingredient is adsorbed on an oil absorbing agent such as dextrin and uniformly dispersed in tablets, or an oil absorbing agent is used. There has been a method in which an active ingredient is absorbed into a drug to give a granule or a tablet, which is mixed with a foaming component containing a carbonate and an acid as a core to form a tablet (JP-A-61-2).
77611 publication).

【0003】[0003]

【発明が解決しようとする課題】しかしながら、上記の
方法では、打錠時の圧力によるしみ出しの問題がある。
すなわち、有効成分が錠剤中に均一に分散しているた
め、しみ出しが多く、有効成分の分解による効果の低下
や異臭発生が起こり、経時安定性が悪いという欠点があ
った。しみ出しを防止するためには、吸油剤を多量に用
いる方法があるが必ずしも十分防止できなかった。従っ
て本発明の目的は、液状の有効成分のしみ出しや分解が
なく、経時的に安定な発泡性錠剤型浴用剤を提供するこ
とにある。
However, the above method has a problem of exudation due to the pressure during tableting.
That is, since the active ingredient is uniformly dispersed in the tablet, there are many bleeding points, the effect is degraded due to the decomposition of the active ingredient, an offensive odor is generated, and the stability over time is poor. In order to prevent the exudation, there is a method of using a large amount of oil absorbing agent, but it could not be sufficiently prevented. Therefore, an object of the present invention is to provide an effervescent tablet-type bath agent that is stable and does not exude or decompose the liquid active ingredient.

【0004】[0004]

【課題を解決するための手段】斯かる実情に鑑み本発明
者らは鋭意研究を行なった結果、液状有効成分を含有す
るカプセル化物を核部分に含有させ、これと発泡剤とを
組み合せれば、有効成分のしみ出し、分解等がない安定
な発泡性錠剤型浴用剤が得られることを見出し、本発明
を完成した。
In view of such circumstances, the inventors of the present invention have conducted diligent research, and as a result, when an encapsulated product containing a liquid active ingredient is contained in the core part and this is combined with a foaming agent, The present invention has been completed by finding that a stable effervescent tablet-type bath agent without bleeding or decomposition of the active ingredient can be obtained.

【0005】すなわち、本発明は、核含有錠剤型浴用剤
において、核部分に液状成分を封入してなるカプセル化
物を含有し、その核外部分に発泡性浴用成分を含有する
ことを特徴とする発泡性錠剤型浴用剤を提供するもので
ある。
That is, the present invention is characterized in that the core-containing tablet-type bath agent contains an encapsulated product in which a liquid component is encapsulated in the core portion, and the effervescent bath component is contained in the outer portion of the core. An effervescent tablet-type bath agent is provided.

【0006】本発明の浴用剤のカプセル化物中の液状有
効成分としては特に限定されないが、生薬抽出物、血行
促進剤等が好ましい。
The liquid active ingredient in the encapsulated product of the bath agent of the present invention is not particularly limited, but crude drug extracts, blood circulation promoters and the like are preferable.

【0007】生薬抽出物としては、例えばセンキュウ、
トウヒ、トウキ、ショウキョウ、ガイヨウ、チンピ、カ
ミツレ、モモ葉などの生薬からの抽出物が挙げられる。
これらの生薬抽出物は、水;エタノール、イソプロパノ
ールなどの低級アルコール;大豆油、オリーブ油などの
植物油;ミリスチン酸イソプロピルなどのエステル油;
多価アルコールなどの溶剤又はこれらの2種以上の混合
溶剤で抽出する方法などにより得られる。血行促進剤と
しては、トコフェロール、酢酸トコフェロールなどのビ
タミンE誘導体や、ニコチン酸メチル、ニコチン酸ベン
ジル、ニコチン酸トコフェロールなどのニコチン酸誘導
体、ブチルフタリド、ペンチルフタリド、オクチルフタ
リドなどのフタリド誘導体などが挙げられる。その他、
油脂類、ロウ類、炭化水素類、高級脂肪酸類、高級アル
コール類、エステル類、精油類、シリコーン類、香料な
どを含有させてもよい。
Examples of the herbal medicine extract include senkyu,
Examples include extracts from crude drugs such as spruce, sugar beet, ginger, cabbage, chimpi, chamomile and peach leaves.
These crude drug extracts are water; lower alcohols such as ethanol and isopropanol; vegetable oils such as soybean oil and olive oil; ester oils such as isopropyl myristate;
It can be obtained by a method such as extraction with a solvent such as polyhydric alcohol or a mixed solvent of two or more of these. Examples of blood circulation promoters include vitamin E derivatives such as tocopherol and tocopherol acetate, nicotinic acid derivatives such as methyl nicotinate, benzyl nicotinate and tocopherol nicotinate, and phthalide derivatives such as butylphthalide, pentylphthalide and octylphthalide. To be Other,
Oils and fats, waxes, hydrocarbons, higher fatty acids, higher alcohols, esters, essential oils, silicones, fragrances and the like may be contained.

【0008】また、本発明浴用剤中のカプセル化物のカ
プセル皮膜形成用物質としては、ゼラチン、可溶性デン
プン、グリセリン、ソルビトール等汎用のものが使用で
きる。
As the substance for forming a capsule film of the encapsulated product in the bath agent of the present invention, general-purpose substances such as gelatin, soluble starch, glycerin and sorbitol can be used.

【0009】本発明に用いるカプセル化物は、一般的な
スプレードライング法、液中硬化皮膜法、コアセルベー
ション法、液中乾燥法等により得ることができるが、本
発明においては、多重ノズル、特に2重ノズルを有する
装置を用いたシームレスカプセル化法によることが好ま
しい。
The encapsulated product used in the present invention can be obtained by a general spray drying method, a submerged cured coating method, a coacervation method, a submerged drying method or the like. The seamless encapsulation method using an apparatus having a double nozzle is preferable.

【0010】すなわち、順次増大する直径を有する2重
ノズルを用いて該2重ノズルの外側ノズルから皮膜形成
体を、内側ノズルから液状有効成分の液体を気相又は液
相中で連続的に吐出させて、2層液滴を形成させ、次い
で該2層液滴の皮膜形成用液体を硬化又はゲル化させて
シームレスカプセル化物を得る方法が好ましい。
That is, by using a double nozzle having a gradually increasing diameter, a film forming body is continuously discharged from an outer nozzle of the double nozzle, and a liquid of a liquid active ingredient is continuously discharged from an inner nozzle in a gas phase or a liquid phase. A preferable method is to form a two-layer droplet and then cure or gel the film-forming liquid of the two-layer droplet to obtain a seamless encapsulated product.

【0011】カプセル化物は直径が0.5〜5mm、皮膜
率(=皮膜重量/カプセル化物重量)が5〜60%、皮
膜厚さが0.02〜1mmの範囲のものが好ましい。ま
た、液状有効成分の配合量は目的により適宜決定される
が、一般的に全浴用剤中0.01〜20重量%(以下、
単に「%」で示す)、特に0.1〜10%となるよう配
合することが好ましい。核部分は、カプセル化物を主と
して含有するが、後述する炭酸塩、酸及びそれ以外の浴
用剤用原料を含有させることもできる。
The encapsulated material preferably has a diameter of 0.5 to 5 mm, a coating rate (= coating weight / encapsulated material weight) of 5 to 60%, and a coating thickness of 0.02 to 1 mm. The amount of the liquid active ingredient is appropriately determined depending on the purpose, but generally 0.01 to 20% by weight (hereinafter,
It is preferable that the content is simply “%”), particularly 0.1 to 10%. The core part mainly contains an encapsulated product, but it is also possible to contain a carbonate, an acid, and other raw materials for bath agents described later.

【0012】本発明の浴用剤は、発泡型であるため、炭
酸塩等及び酸を核外部分に含有する。
Since the bath agent of the present invention is of a foaming type, it contains a carbonate or the like and an acid in the extranuclear portion.

【0013】炭酸塩等としては、例えば、炭酸水素ナト
リウム、炭酸ナトリウム、セスキ炭酸ナトリウム、炭酸
カリウム、炭酸マグネシウムなどが挙げられ、これらは
単独又は2種以上を組み合せて使用される。
Examples of the carbonate and the like include sodium hydrogen carbonate, sodium carbonate, sodium sesquicarbonate, potassium carbonate, magnesium carbonate and the like, and these may be used alone or in combination of two or more kinds.

【0014】酸としては、有機酸として、例えばフマル
酸、コハク酸、酒石酸、アジピン酸、ピロリドンカルボ
ン酸などとこれらの酸性塩が、無機塩として、ホウ酸、
燐酸二水素ナトリウムなどが挙げられる。これら炭酸塩
等及び有機酸は、それぞれ浴用剤全体の10〜80%、
特に30〜60%となるよう配合することが好ましい。
Examples of the acid include organic acids such as fumaric acid, succinic acid, tartaric acid, adipic acid and pyrrolidonecarboxylic acid, and acid salts thereof, and inorganic salts such as boric acid,
Examples include sodium dihydrogen phosphate. These carbonates and organic acids account for 10 to 80% of the total bath agent,
In particular, it is preferable to add 30 to 60%.

【0015】本発明の浴用剤には、通常浴用剤に使用さ
れている公知の下記記載の浴用剤用原料を配合すること
ができるが、配合できる浴用剤用原料は下記に例示され
るものに限定されるものではない。 (ア)無機化合物及び無機塩類 塩化ナトリウム、塩化カリウム、塩化アンモニウム、硫
化カリウム、硫化ナトリウム、酸化カルシウム、酸化マ
グネシウム、硝酸カリウム、硝酸ナトリウム、硝酸カル
シウム、亜硫化鉄、メタケイ酸、無水ケイ酸、中性白
土、チオ硫酸ナトリウム、ポリリン酸ナトリウム、メタ
リン酸ナトリウム、リン酸ナトリウム、リン酸水素カル
シウム、臭化カリウム、消石灰、次亜硫酸ナトリウム、
チオ硫酸カルシウム、水酸化ナトリウム、雲母末、ホウ
酸、ホウ砂等
The well-known raw materials for bath agents described below, which are commonly used in bath agents, can be added to the bath agent of the present invention. It is not limited. (A) Inorganic compounds and inorganic salts Sodium chloride, potassium chloride, ammonium chloride, potassium sulfide, sodium sulfide, calcium oxide, magnesium oxide, potassium nitrate, sodium nitrate, calcium nitrate, iron sulfite, metasilicic acid, silicic anhydride, neutral Clay, sodium thiosulfate, sodium polyphosphate, sodium metaphosphate, sodium phosphate, calcium hydrogen phosphate, potassium bromide, slaked lime, sodium hyposulfite,
Calcium thiosulfate, sodium hydroxide, mica powder, boric acid, borax, etc.

【0016】(イ)精油、香料等 ハッカ油、ジャスミン油、樟脳油、ヒノキ油、トウヒ
油、リュウ油、ミカン油、オレンジ油、ユズ油、ラベン
ダー油、ベン油、クローブ油、ヒバ油、バラ油、ユーカ
リ油、レモン油、タイム油、ペパーミント油、セージ
油、ベルガモット油、菖蒲油、パイン油、メントール、
dl−メントール、l−メントール、シネオール、オイゲ
ノール、シトラール、シトロネロール、シトロネラー
ル、ボルネオール、リナロール、ゲラニオール、フェニ
ルエチルアルコール、ベンジルアセテート、カンファ
ー、チモール、スピラントール、ピネン、テルペン系化
合物等
(A) Essential oils, fragrances, etc. Mint oil, jasmine oil, camphor oil, cypress oil, spruce oil, ryu oil, mandarin oil, orange oil, yuzu oil, lavender oil, ben oil, clove oil, hiba oil, rose Oil, eucalyptus oil, lemon oil, thyme oil, peppermint oil, sage oil, bergamot oil, iris oil, pine oil, menthol,
dl-menthol, l-menthol, cineol, eugenol, citral, citronellol, citronellal, borneol, linalool, geraniol, phenylethyl alcohol, benzyl acetate, camphor, thymol, spilanthol, pinene, terpene compounds, etc.

【0017】(ウ)色素類 青色1号、青色2号、黄色4号、黄色5号、緑色3号、
緑色4号、緑色204号、黄色202号の(1)等の厚
生省令により定められたタール色素別表I及びIIの色
素、クロロフィル、リボフラビン、クロシン、アントラ
キノン、コチニール、カンタキサンチン、紅花等の食品
添加物として認められている天然色素等
(C) Dyes Blue No. 1, Blue No. 2, Yellow No. 4, Yellow No. 5, Green No. 3,
Tar dyes such as Green No. 4, Green No. 204, Yellow No. 202 (1), etc. specified by the Ordinance of the Ministry of Health and Welfare, food additives such as chlorophyll, riboflavin, crocin, anthraquinone, cotinyl, canthaxanthin and safflower Natural pigments recognized as products

【0018】(エ)微粉体 一般に化粧用粉体と称されるもので、アクリル樹脂、ス
チレン樹脂、エポキシ樹脂、シリコン樹脂、ナイロン、
ポリエチレン、ポリプロピレン、ポリ塩化ビニル、PE
T、ポリテトラフルオロエタン等の高分子、この高分子
化合物のコポリマー、ケイ酸カルシウム、天然ケイ酸ア
ルミニウム、合成ケイ酸アルミニウム、ゼオライト、酸
化チタン、タルク、カオリン、マイカ、ベントナイト等
(D) Fine powder Generally referred to as cosmetic powder. Acrylic resin, styrene resin, epoxy resin, silicone resin, nylon,
Polyethylene, polypropylene, polyvinyl chloride, PE
Polymers such as T and polytetrafluoroethane, copolymers of these polymer compounds, calcium silicate, natural aluminum silicate, synthetic aluminum silicate, zeolite, titanium oxide, talc, kaolin, mica, bentonite, etc.

【0019】(オ)水溶性高分子 PEG、CMC、PVP、ゼラチン、寒天、アラビアガ
ム、グアーガム等
(E) Water-soluble polymer PEG, CMC, PVP, gelatin, agar, gum arabic, guar gum, etc.

【0020】(カ)その他 湯の花、イオウ、カゼイン、サリチル酸ナトリウム、い
り糠、雲母末、デキストリン、中性白土、脱脂粉乳、尿
素、アミノ酸類、界面活性剤、糖類等を配合することが
できる。
(F) Others Yunohana, sulfur, casein, sodium salicylate, rice bran, mica powder, dextrin, neutral clay, skim milk powder, urea, amino acids, surfactants, sugars and the like can be added.

【0021】更に、本発明の浴用剤組成物は、上記した
もの以外にも、必要に応じて殺菌防止剤(例えば安息香
酸エステル、ソルビン酸等)、金属封鎖剤(例えばED
TA、NTA等)、蛋白分解酵素などその他の配合剤を
配合できる。
Further, the bath agent composition of the present invention may include, in addition to those mentioned above, an antibacterial agent (eg, benzoic acid ester, sorbic acid, etc.) and a sequestering agent (eg, ED), if necessary.
Other compounding agents such as TA, NTA, etc.) and proteolytic enzymes can be added.

【0022】本発明の浴用剤を製造するには、上記のカ
プセル化物が核部分に含有されるようにし、打錠する。
In order to produce the bath preparation of the present invention, the above encapsulated product is contained in the core portion and tableted.

【0023】具体的には、例えば、カプセル化物以外の
核外部成分を型に充填し、その上にカプセル化物と必要
によりこれ以外の核外成分をのせ、更に核外部成分をの
せプレスする方法が挙げられる。
Specifically, for example, a method of filling a mold with an external core component other than the encapsulated product, placing the encapsulated product and, if necessary, other external core components on the mold, and further placing the external core component on the mold and pressing. Can be mentioned.

【0024】[0024]

【発明の効果】本発明のカプセル含有発泡性錠剤型浴用
剤は、液状の有効成分のしみ出しや、分解、変質がなく
経時的に安定である。
INDUSTRIAL APPLICABILITY The capsule-containing effervescent tablet-type bath agent of the present invention is stable over time without exudation, decomposition or deterioration of the liquid active ingredient.

【0025】[0025]

【実施例】以下、実施例を挙げて本発明を更に詳細に説
明するが、本発明はこれらに限定されるものではない。
The present invention will be described in more detail with reference to examples, but the present invention is not limited thereto.

【0026】実施例1 カプセルの内容液として、センキュウ熱水抽出エキス2
0%、ブチルフタリド80%からなる液状有効成分を用
意した。皮膜液として、ゼラチン30%、グリセリン4
%、水66%の液を準備した。装置は、順次増大する2
重ノズル(内側ノズル口径0.7mm、外側ノズル口径
1.5mm)を有する装置を用いた。この内側ノズルより
上記の内容液を流量7.0〔g/min〕で、また外側ノ
ズルより上記組成の皮膜液を70℃に保ったまま、流量
12.0〔g/min〕で5℃に冷却した流動パラフィン
中に、同時に吐出させて、2層液滴を生成した。これを
エタノールで洗浄し、常温にて乾燥させてカプセル化物
を得た。該カプセル化物の粒子径をノギスで測定したと
ころ平均粒子径は1.0mmであり、粒子径分布の変動係
数は5.0%であった。また皮膜率(=皮膜重量/カプ
セル化物重量)を測定したところ30.0%であった。
Example 1 As a content liquid of a capsule, senkyu hot water extract 2
A liquid active ingredient consisting of 0% and butylphthalide 80% was prepared. As a film liquid, gelatin 30%, glycerin 4
%, 66% water was prepared. The equipment is increasing 2
An apparatus having a heavy nozzle (inner nozzle diameter 0.7 mm, outer nozzle diameter 1.5 mm) was used. From the inner nozzle, the above content liquid was flowed at 7.0 [g / min], and from the outer nozzle, the coating liquid having the above composition was kept at 70 ° C, and the flow rate was 12.0 [g / min] at 5 ° C. Simultaneous discharge was performed into cooled liquid paraffin to generate a two-layer droplet. This was washed with ethanol and dried at room temperature to obtain an encapsulated product. When the particle size of the encapsulated product was measured with a caliper, the average particle size was 1.0 mm and the coefficient of variation of the particle size distribution was 5.0%. The coating rate (= coating weight / capsule weight) was measured and found to be 30.0%.

【0027】一方、核外部成分(錠剤ベース)として、
炭酸水素ナトリウム20%、炭酸ナトリウム20%、コ
ハク酸45%、PEG5%、色素微量、香料微量をあら
かじめ混合しておいた。
On the other hand, as the core external component (tablet base),
Sodium hydrogencarbonate 20%, sodium carbonate 20%, succinic acid 45%, PEG 5%, a small amount of dye and a small amount of perfume were mixed in advance.

【0028】この核外部成分(錠剤ベース)を25gと
り、直径50mmφの円筒状の型に充填し、予圧をかけた
後、その上にカプセル化物3g(有効成分2.1g)を
のせ、更に、核外部成分を22g添加し、ゲージ圧20
0kg/cm2でプレス成形し、50gの本発明品たる錠剤
を得た。
25 g of this core external component (tablet base) was filled into a cylindrical mold having a diameter of 50 mmφ, and after precompression, 3 g of the encapsulated product (2.1 g of active ingredient) was placed on it, and further, 22 g of external components are added, and the gauge pressure is 20
Press molding was carried out at 0 kg / cm 2 to obtain 50 g of the tablet of the present invention.

【0029】実施例2 カプセルの内容液として、センキュウ熱水抽出エキス2
0%、ブチルフタリド80%からなる液状有効成分を用
意した。皮膜液としてゼラチン30%、D−ソルビトー
ル4%、水66%の液を準備し、実施例1と同様にして
シームレスカプセル化し、エタノールで洗浄し、常温に
て乾燥させ、粒子径約1mmφ、皮膜率30%のカプセル
を得た。
Example 2 As the content liquid of the capsule, senkyu hot water extract 2
A liquid active ingredient consisting of 0% and butylphthalide 80% was prepared. As a coating liquid, a liquid containing 30% gelatin, 4% D-sorbitol and 66% water was prepared, seamlessly encapsulated in the same manner as in Example 1, washed with ethanol, and dried at room temperature to give a particle diameter of about 1 mmφ and a coating. Capsules with a rate of 30% were obtained.

【0030】実施例1と同様の核外部成分(錠剤ベー
ス)を22gとり直径50mmφの円筒状の型に充填し、
予圧をかけた後、その上にカプセル化物3g(有効成分
2.1g)と核外部成分3gとを混合したものをのせ、
更に核外部成分を22g添加し、ゲージ圧200kg/cm
2でプレス成形し、50gの錠剤を得た。
22 g of the same core external component (tablet base) as in Example 1 was filled in a cylindrical mold having a diameter of 50 mmφ,
After applying a preload, a mixture of 3 g of the encapsulated product (2.1 g of the active ingredient) and 3 g of the external core component is placed on it,
Furthermore, 22 g of external components are added, and the gauge pressure is 200 kg / cm.
Press molding was carried out at 2 to obtain tablets of 50 g.

【0031】比較例1 センキュウ熱水抽出エキス20%、ブチルフタリド80
%からなる液状有効成分を2倍量(重量比)のデキスト
リンで粉末化した。外殻成分(錠剤ベース)として、炭
酸水素ナトリウム20%、炭酸ナトリウム20%、コハ
ク酸45%、PEG5%、色素微量、香料微量をあらか
じめ混合しておいた。この外殻成分(錠剤ベース)を2
5gとり、直径50mmφの円筒状の型に充填し、予圧を
かけた後、その上に粉末化物3g(有効成分1.0g)
をのせ、更に、外殻成分を22g添加し、ゲージ圧20
0kg/cm2でプレス成形し、50gの錠剤を得た。
Comparative Example 1 Senkyu hot water extract 20%, butylphthalide 80
% Of the liquid active ingredient was pulverized with a double amount (weight ratio) of dextrin. As an outer shell component (tablet base), sodium hydrogencarbonate 20%, sodium carbonate 20%, succinic acid 45%, PEG 5%, a small amount of pigment and a small amount of fragrance were mixed in advance. 2 parts of this shell component (tablet base)
After taking 5 g, it was filled in a cylindrical mold with a diameter of 50 mm and preloaded, and then 3 g of powdered product (1.0 g of active ingredient)
And add 22 g of the shell component, and add a gauge pressure of 20
It was pressed at 0 kg / cm 2 to obtain 50 g of tablets.

【0032】比較例2 センキュウ熱水抽出エキス20%、ブチルフタリド80
%からなる液状有効成分を2倍量(重量比)のデキスト
リンで粉末化した。外殻成分(錠剤ベース)として、炭
酸水素ナトリウム20%、炭酸ナトリウム20%、コハ
ク酸45%、PEG5%、色素微量、香料微量をあらか
じめ混合しておいた。この外殻成分(錠剤ベース)を2
2gとり、直径50mmφの円筒上の型に充填し、予圧を
かけた後、その上に粉末化物6.3g(有効成分2.1
g)をのせ、更に、外殻成分を21.7g添加し、ゲー
ジ圧200kg/cm2でプレス成形し、50gの錠剤を得
た。
Comparative Example 2 Senkyu hot water extract 20%, butylphthalide 80
% Of the liquid active ingredient was pulverized with a double amount (weight ratio) of dextrin. As an outer shell component (tablet base), sodium hydrogencarbonate 20%, sodium carbonate 20%, succinic acid 45%, PEG 5%, a small amount of pigment and a small amount of fragrance were mixed in advance. 2 parts of this shell component (tablet base)
After taking 2 g, it was filled in a cylindrical mold having a diameter of 50 mmφ and preloaded, and then 6.3 g of powdered product (active ingredient 2.1
g) was added, 21.7 g of an outer shell component was further added, and press molding was carried out at a gauge pressure of 200 kg / cm 2 to obtain 50 g of tablets.

【0033】比較例3 センキュウ熱水抽出エキス20%、ブチルフタリド80
%からなる液状有効成分を、7分の3量(重量比)のデ
キストリンで粉末化した。外殻成分(錠剤ベース)とし
て、炭酸水素ナトリウム20%、炭酸ナトリウム20
%、コハク酸45%、PEG5%、色素微量、香料微量
をあらかじめ混合しておいた。この外殻成分(錠剤ベー
ス)を25gとり、直径50mmφの円筒状の型に充填
し、予圧をかけた後、その上に粉末化物3g(有効成分
2.1g)をのせ、更に、外殻成分を22g添加し、ゲ
ージ圧200kg/cm2でプレス成形し、50gの錠剤を
得た。
COMPARATIVE EXAMPLE 3 Senkyu hot water extract 20%, butylphthalide 80
% Of the liquid active ingredient was powdered with 3/7 amount (weight ratio) of dextrin. 20% sodium hydrogen carbonate and 20 sodium carbonate as outer shell components (tablet base)
%, Succinic acid 45%, PEG 5%, a small amount of dye, and a small amount of fragrance. Take 25 g of this outer shell component (tablet base), fill it in a cylindrical mold with a diameter of 50 mmφ, apply a preload, and then put 3 g of powdered product (2.1 g of active ingredient) on it, and further coat the outer shell component. Was added and the mixture was pressed at a gauge pressure of 200 kg / cm 2 to obtain 50 g of tablets.

【0034】試験例1 上記実施例及び比較例で得られた浴用剤を下記の如く試
験し、評価した。
Test Example 1 The bath agents obtained in the above Examples and Comparative Examples were tested and evaluated as follows.

【0035】(1)錠剤を溶解したあとの湯のにおいの
評価 40℃の湯(5l)に1錠を溶かしたあとの湯のにおい
を次の基準により評価した。結果を表1に示す。 ○;設計品と同等。 △;やや異臭あり。 ×;異臭あり。
(1) Evaluation of hot water odor after dissolving tablets The hot water odor after dissolving one tablet in hot water (5 l) at 40 ° C. was evaluated according to the following criteria. The results are shown in Table 1. ○: Equivalent to the designed product. Δ: Slight offensive odor. X: There is an offensive odor.

【0036】[0036]

【表1】 [Table 1]

【0037】(2)保温効果 被験者10名を対照として、実施例1、実施例2、比較
例1、比較例2の浴剤添加湯(50g/150l)に1
0分間入浴させ、入浴前後の皮膚表面温をサーモグラフ
ィーを用いて比較した。湯温は40℃、室温は25℃と
した。結果を表2に示す。
(2) Insulating effect Ten subjects were used as controls, and 1 part was added to the bath-added hot water (50 g / 150 l) of Example 1, Example 2, Comparative Example 1 and Comparative Example 2.
After bathing for 0 minutes, the skin surface temperature before and after bathing was compared using thermography. The hot water temperature was 40 ° C and the room temperature was 25 ° C. The results are shown in Table 2.

【0038】[0038]

【表2】 [Table 2]

【0039】表1より、本発明品は、有効成分のしみ出
し、変質がないことが判る。また表2から本発明品は、
有効成分の分解、変質がないことが判る。
From Table 1, it can be seen that the product of the present invention has neither exudation nor alteration of the active ingredient. Further, from Table 2, the product of the present invention is
It can be seen that there is no decomposition or alteration of the active ingredient.

【0040】実施例3 カプセルの内容液として、ニコチン酸ベンジル10%、
オクチルフタリド90%からなる液状有効成分を用意し
た。皮膜液として、ゼラチン30%、ソルビトール4
%、水66%の液を準備し、実施例1と同様にしてシー
ムレスカプセル化し、エタノールで洗浄し、常温にて乾
燥させ、粒子径約1mmφ、皮膜率30%のカプセルを得
た。核外部成分(錠剤ベース)として、炭酸水素ナトリ
ウム20%、炭酸ナトリウム20%、コハク酸45%、
PEG5%、色素微量、香料微量をあらかじめ混合して
おく。この核外部成分(錠剤ベース)を25gとり、直
径50mmφの円筒状の型に充填し、予圧をかけた後、そ
の上にカプセル化物3g(有効成分2.1g)をのせ、
更に、核外部成分を22g添加し、ゲージ圧200kg/
cm2でプレス成形し、50gの錠剤を得た。このもの
は、有効成分の効果が経時的に衰えない安定な浴用剤で
あった。
Example 3 As the content liquid of the capsule, benzyl nicotinate 10%,
A liquid active ingredient consisting of 90% octyl phthalide was prepared. As a film liquid, gelatin 30%, sorbitol 4
%, 66% water was prepared, seamless capsules were prepared in the same manner as in Example 1, washed with ethanol, and dried at room temperature to obtain capsules having a particle diameter of about 1 mmφ and a coating rate of 30%. As external ingredients (tablet base), sodium hydrogencarbonate 20%, sodium carbonate 20%, succinic acid 45%,
PEG 5%, a trace amount of dye, and a trace amount of fragrance are mixed in advance. 25 g of this external component (tablet base) is filled in a cylindrical mold having a diameter of 50 mmφ, and after applying a preload, 3 g of the encapsulated substance (2.1 g of active ingredient) is placed on it.
Furthermore, 22 g of external components are added, and the gauge pressure is 200 kg /
It was pressed at cm 2 to obtain 50 g of tablets. This was a stable bath preparation in which the effect of the active ingredient did not deteriorate over time.

【手続補正書】[Procedure amendment]

【提出日】平成5年9月14日[Submission date] September 14, 1993

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0026[Correction target item name] 0026

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0026】実施例1 カプセルの内容液として、センキュウ熱水抽出エキス2
0%、ブチルフタリド80%からなる液状有効成分を用
意した。皮膜液として、ゼラチン30%、グリセリン4
%、水66%の液を準備した。装置は、順次増大する直
径を有する2重ノズル(内側ノズル口径0.7mm、外
側ノズル口径1.5mm)を有する装置を用いた。この
内側ノズルより上記の内容液を流量7.0〔g/mi
n〕で、また外側ノズルより上記組成の皮膜液を70℃
に保ったまま、流量12.0〔g/min〕で5℃に冷
却した流動パラフィン中に、同時に吐出させて、2層液
滴を生成した。これをエタノールで洗浄し、常温にて乾
燥させてカプセル化物を得た。該カプセル化物の粒子径
をノギスで測定したところ平均粒子径は1.0mmであ
り、粒子径分布の変動係数は5.0%であった。また皮
膜率(=皮膜重量/カプセル化物重量)を測定したとこ
ろ30.0%であった。
Example 1 As a content liquid of a capsule, senkyu hot water extract 2
A liquid active ingredient consisting of 0% and butylphthalide 80% was prepared. As a film liquid, gelatin 30%, glycerin 4
%, 66% water was prepared. As the apparatus, an apparatus having a double nozzle (inner nozzle diameter 0.7 mm, outer nozzle diameter 1.5 mm) having successively increasing diameters was used. The flow rate of the above content liquid was 7.0 [g / mi from this inner nozzle.
n], and a coating liquid of the above composition at 70 ° C. from the outer nozzle.
While maintaining the above, the liquid was simultaneously discharged into liquid paraffin cooled to 5 ° C. at a flow rate of 12.0 [g / min] to generate two-layer droplets. This was washed with ethanol and dried at room temperature to obtain an encapsulated product. When the particle size of the encapsulated product was measured with a caliper, the average particle size was 1.0 mm, and the variation coefficient of the particle size distribution was 5.0%. The coating rate (= coating weight / capsule weight) was measured and found to be 30.0%.

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0037[Name of item to be corrected] 0037

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0037】(2)保温効果 被験者10名を対照として、実施例1、実施例2、比較
例1、比較例2の浴剤を50℃、20日間保存し、その
保存後の浴剤を添加した湯(50g/150l)に10
分間入浴させ、入浴前後の皮膚表面温をサーモグラフィ
ーを用いて比較した。湯温は40℃、室温は25℃とし
た。結果を表2に示す。
(2) Heat-retaining effect Using 10 subjects as controls, the bath salts of Example 1, Example 2, Comparative Example 1 and Comparative Example 2 were stored at 50 ° C. for 20 days, and the bath agents after the storage were added. 10 in hot water (50g / 150l)
After bathing for a minute, the skin surface temperature before and after bathing was compared using thermography. The hot water temperature was 40 ° C and the room temperature was 25 ° C. The results are shown in Table 2.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 核含有錠剤型浴用剤において、核部分に
液状成分を封入してなるカプセル化物を含有し、その核
外部分に発泡性浴用成分を含有することを特徴とする発
泡性錠剤型浴用剤。
1. An effervescent tablet mold comprising a core-containing tablet type bath agent, which contains an encapsulated product in which a liquid component is encapsulated in the core part, and which contains an effervescent bath component in the outer core part. Bath agent.
JP5212968A 1993-08-27 1993-08-27 Effervescent tablet type bath agent containing capsules Expired - Fee Related JP2544297B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5212968A JP2544297B2 (en) 1993-08-27 1993-08-27 Effervescent tablet type bath agent containing capsules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5212968A JP2544297B2 (en) 1993-08-27 1993-08-27 Effervescent tablet type bath agent containing capsules

Publications (2)

Publication Number Publication Date
JPH0769864A true JPH0769864A (en) 1995-03-14
JP2544297B2 JP2544297B2 (en) 1996-10-16

Family

ID=16631284

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5212968A Expired - Fee Related JP2544297B2 (en) 1993-08-27 1993-08-27 Effervescent tablet type bath agent containing capsules

Country Status (1)

Country Link
JP (1) JP2544297B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007210986A (en) * 2006-02-13 2007-08-23 Kao Corp Flexible built-in tablet
JP2010260800A (en) * 2009-04-30 2010-11-18 Kao Corp Method for producing liquid-impregnated porous solid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277611A (en) * 1985-06-03 1986-12-08 Kao Corp Weakly acidic bathing agent
JPH05155754A (en) * 1991-12-03 1993-06-22 Kao Corp Bath agent composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277611A (en) * 1985-06-03 1986-12-08 Kao Corp Weakly acidic bathing agent
JPH05155754A (en) * 1991-12-03 1993-06-22 Kao Corp Bath agent composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007210986A (en) * 2006-02-13 2007-08-23 Kao Corp Flexible built-in tablet
JP2010260800A (en) * 2009-04-30 2010-11-18 Kao Corp Method for producing liquid-impregnated porous solid

Also Published As

Publication number Publication date
JP2544297B2 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
JPH09175992A (en) Capsule-containing tablet type bath agent
US5254294A (en) Soft gelatin capsules
US4732759A (en) Bath preparations and method for producing the same
US6569438B1 (en) Multiphase stick preparation
MX2007009167A (en) Spray-dried compositions and their uses.
JPH0314514A (en) Perfume composition with deodorizing or anti-sweating action and deodorizing or anti-sweating apparatus or product
JP6681628B2 (en) Effervescent skin external preparation
JP2544297B2 (en) Effervescent tablet type bath agent containing capsules
KR870004664A (en) Oral garlic preparations and methods for making the same
CA2772144A1 (en) Scented capsules
JP7494421B2 (en) Granule-blended effervescent tablet
JP6072186B1 (en) Effervescent compression molding bath
US3159546A (en) Capsule sealing composition
JPH07502912A (en) Method for producing soft gelatin capsules based on the dropping method
JPH08169811A (en) Toothpaste composition
JP2506048B2 (en) Capsule-containing bath agent composition
JPS623125B2 (en)
JPS638309A (en) Bathing agent or cosmetic, dissolved in use and containing clathrate of aromatic essential oil component
JPH0764718B2 (en) Bath composition
JP2589257B2 (en) Bath composition
JP2006325542A (en) Method for producing α-lipoic acid oil-coated powder and product thereof
JP5838104B2 (en) Method for producing liquid-impregnated solid
JPS607962B2 (en) Sticky powder cosmetics
CN106511125A (en) Eupatorium fortunei turcz compound solid-state essential oil and uses thereof, eupatorium fortunei turcz compound solid-state essential oil capsule preparation method
JPH09249552A (en) Bath composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20080725

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080725

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090725

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090725

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100725

Year of fee payment: 14

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110725

Year of fee payment: 15

LAPS Cancellation because of no payment of annual fees